Detecting tissue-specific early warning signals for complex diseases based on dynamical network biomarkers: study of type 2 diabetes by cross-tissue analysis

Identifying early warning signals of critical transitions during disease progression is a key to achieving early diagnosis of complex diseases. By exploiting rich information of high-throughput data, a novel model-free method has been developed to detect early warning signals of diseases. Its theoretical foundation is based on dynamical network biomarker (DNB), which is also called as the driver (or leading) network of the disease because components or molecules in DNB actually drive the whole system from one state (e.g. normal state) to another (e.g. disease state). In this article, we first reviewed the concept and main results of DNB theory, and then applied the new method to the analysis of type 2 diabetes mellitus (T2DM). Specifically, based on the temporal-spatial gene expression data of T2DM, we identified tissue-specific DNBs corresponding to the critical transitions occurring in liver, adipose and muscle during T2DM development and progression. Actually, we found that there are two different critical states during T2DM development characterized as responses to insulin resistance and serious inflammation, respectively. Interestingly, a new T2DM-associated function, i.e. steroid hormone biosynthesis, was discovered, and those related genes were significantly dysregulated in liver and adipose at the first critical transition during T2DM deterioration. Moreover, the dysfunction of genes related to responding hormone was also detected in muscle at the similar period. Based on the functional and network analysis on pathogenic molecular mechanism of T2DM, we showed that most of DNB genes, in particular the core ones, tended to be located at the upstream of biological pathways, which implied that DNB genes act as the causal factors rather than the consequence to drive the downstream molecules to change their transcriptional activities. This also validated our theoretical prediction of DNB as the driver network. As shown in this study, DNB can not only signal the emergence of the critical transitions for early diagnosis of diseases, but can also provide the causal network of the transitions for revealing molecular mechanisms of disease initiation and progression at a network level.

[1]  P. Muriel,et al.  Role of glutathione, lipid peroxidation and antioxidants on acute bile-duct obstruction in the rat. , 1999, Biochimica et biophysica acta.

[2]  Xiang-Sun Zhang,et al.  APG: an Active Protein-Gene Network Model to Quantify Regulatory Signals in Complex Biological Systems , 2013, Scientific Reports.

[3]  Johanne Tremblay,et al.  Sucrose feeding during pregnancy and lactation elicits distinct metabolic response in offspring of an inbred genetic model of metabolic syndrome. , 2007, American journal of physiology. Endocrinology and metabolism.

[4]  Xiang-Sun Zhang,et al.  NOA: a novel Network Ontology Analysis method , 2011, Nucleic acids research.

[5]  Luonan Chen,et al.  ellipsoidFN: a tool for identifying a heterogeneous set of cancer biomarkers based on gene expressions , 2012, Nucleic acids research.

[6]  Patrizio Odetti,et al.  Is Type 2 Diabetes a Different Disease in Obese and Nenobese Patients? , 1998, Diabetes Care.

[7]  M. Hayden,et al.  Islet amyloid, metabolic syndrome, and the natural progressive history of type 2 diabetes mellitus. , 2002, JOP : Journal of the pancreas.

[8]  Xing-Ming Zhao,et al.  Detecting early-warning signals of type 1 diabetes and its leading biomolecular networks by dynamical network biomarkers , 2013, BMC Medical Genomics.

[9]  M. Małecki Genetics of type 2 diabetes mellitus. , 2005, Diabetes research and clinical practice.

[10]  Luonan Chen,et al.  Rewiring drug-activated p53-regulatory network from suppressing to promoting tumorigenesis. , 2012, Journal of molecular cell biology.

[11]  Luonan Chen,et al.  Whole-exome sequencing reveals recurrent somatic mutation networks in cancer. , 2013, Cancer letters.

[12]  K. Petersen,et al.  Reversal of muscle insulin resistance by weight reduction in young, lean, insulin-resistant offspring of parents with type 2 diabetes , 2012, Proceedings of the National Academy of Sciences.

[13]  S. Carpenter,et al.  Early-warning signals for critical transitions , 2009, Nature.

[14]  R. J. Chang,et al.  The reproductive phenotype in polycystic ovary syndrome , 2007, Nature Clinical Practice Endocrinology &Metabolism.

[15]  Kazuyuki Aihara,et al.  Modeling Biomolecular Networks in Cells: Structures and Dynamics , 2010 .

[16]  Chen Chen,et al.  Revealing metabolite biomarkers for acupuncture treatment by linear programming based feature selection , 2012, BMC Systems Biology.

[17]  Xia Yang,et al.  Liver and Adipose Expression Associated SNPs Are Enriched for Association to Type 2 Diabetes , 2010, PLoS genetics.

[18]  J. Florez,et al.  The genetics of type 2 diabetes: what have we learned from GWAS? , 2010, Annals of the New York Academy of Sciences.

[19]  T. Valle,et al.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.

[20]  Kazuyuki Aihara,et al.  Identifying critical transitions and their leading biomolecular networks in complex diseases , 2012, Scientific Reports.

[21]  Mark I McCarthy,et al.  Genetics of type 2 diabetes mellitus and obesity—a review , 2008, Annals of medicine.

[22]  S. Agrawal,et al.  T2D-Db: An integrated platform to study the molecular basis of Type 2 diabetes , 2008, BMC Genomics.

[23]  Zhi-Ping Liu,et al.  Network screening of Goto-Kakizaki rat liver microarray data during diabetic progression , 2011, BMC Systems Biology.

[24]  R. Heine,et al.  Induction of insulin resistance by androgens and estrogens. , 1994, The Journal of clinical endocrinology and metabolism.

[25]  Xing-Ming Zhao,et al.  NARROMI: a noise and redundancy reduction technique improves accuracy of gene regulatory network inference , 2013, Bioinform..

[26]  Anton Berns,et al.  Cancer: Gene expression in diagnosis , 2000, Nature.

[27]  E. Jonietz,et al.  Pathology: Cause and effect , 2012, Nature.

[28]  Eric E Schadt,et al.  Cycle Regulation in Islets with Diabetes Susceptibility a Gene Expression Network Model of Type 2 Diabetes Links Cell P

, 2008 .

[29]  A. Mari,et al.  Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes , 2011, Diabetologia.

[30]  Debra C DuBois,et al.  Gene expression analysis of hepatic roles in cause and development of diabetes in Goto-Kakizaki rats. , 2009, The Journal of endocrinology.

[31]  Damjana Rozman,et al.  Regulation of hepatic cytochromes p450 by lipids and cholesterol. , 2011, Current drug metabolism.

[32]  M. Collison,et al.  Sex steroids and insulin resistance. , 2002, Clinical science.

[33]  H. Cortez‐Pinto,et al.  Apoptosis and insulin resistance in liver and peripheral tissues of morbidly obese patients is associated with different stages of non-alcoholic fatty liver disease , 2011, Diabetologia.

[34]  Kazuyuki Aihara,et al.  Dynamical network biomarkers for identifying critical transitions and their driving networks of biologic processes , 2013, Quantitative Biology.

[35]  Peter Nowotny,et al.  Muscle Mitochondrial ATP Synthesis and Glucose Transport/Phosphorylation in Type 2 Diabetes , 2007, PLoS medicine.

[36]  A. Fagan,et al.  Multimodal techniques for diagnosis and prognosis of Alzheimer's disease , 2009, Nature.

[37]  S. K. Frey,et al.  Vitamin A Metabolism and Adipose Tissue Biology , 2011, Nutrients.

[38]  Luonan Chen,et al.  Coexpression network analysis in chronic hepatitis B and C hepatic lesions reveals distinct patterns of disease progression to hepatocellular carcinoma. , 2012, Journal of molecular cell biology.

[39]  Xing-Ming Zhao,et al.  Inferring gene regulatory networks from gene expression data by path consistency algorithm based on conditional mutual information , 2012, Bioinform..

[40]  Kazuyuki Aihara,et al.  Detecting early-warning signals for sudden deterioration of complex diseases by dynamical network biomarkers , 2012, Scientific Reports.

[41]  Marc Montminy,et al.  PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3. , 2004, Nature medicine.

[42]  B. Balkau,et al.  Evaluating the association of common PBX1 variants with type 2 diabetes , 2008, BMC Medical Genetics.

[43]  L. Hansen,et al.  Candidate genes and late-onset type 2 diabetes mellitus. Susceptibility genes or common polymorphisms? , 2003, Danish medical bulletin.

[44]  Donald Chisholm,et al.  The many faces of hepatitis C: Liver disease and type 2 diabetes , 2009, Hepatology.

[45]  Marc Montminy,et al.  PGC-1 promotes insulin resistance in liver through PPAR-α-dependent induction of TRB-3 , 2004, Nature Medicine.

[46]  Xing-Ming Zhao,et al.  Identifying disease genes and module biomarkers by differential interactions , 2012, J. Am. Medical Informatics Assoc..

[47]  Michael Stumvoll,et al.  Type 2 diabetes: principles of pathogenesis and therapy , 2005, The Lancet.

[48]  T. Scully Diabetes in numbers , 2012, Nature.

[49]  Yan Zhang,et al.  Research and applications: An integrated approach to identify causal network modules of complex diseases with application to colorectal cancer , 2013, J. Am. Medical Informatics Assoc..

[50]  Kenneth R Feingold,et al.  Tumor Necrosis Factor–Increased Hepatic Very-Low-Density Lipoprotein Production and Increased Serum Triglyceride Levels in Diabetic Rats , 1990, Diabetes.

[51]  Nicholas J. Wareham,et al.  Genetic Factors in Type 2 Diabetes: The End of the Beginning? , 2005, Science.

[52]  David Tuveson,et al.  Translational medicine: Cancer lessons from mice to humans , 2011, Nature.

[53]  Tao Zeng,et al.  Reconstructing dynamic gene regulatory networks from sample-based transcriptional data , 2012, Nucleic acids research.

[54]  Luonan Chen,et al.  Biomolecular Networks: Methods and Applications in Systems Biology , 2009 .

[55]  Nigam H. Shah,et al.  The coming age of data-driven medicine: translational bioinformatics' next frontier , 2012, J. Am. Medical Informatics Assoc..

[56]  Susumu Goto,et al.  KEGG for integration and interpretation of large-scale molecular data sets , 2011, Nucleic Acids Res..

[57]  Jing He,et al.  Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. , 2002, Diabetes.